Environmental SARS-CoV-2 contamination in hospital rooms of patients with acute COVID-19.

Airborne contamination COVID-19 Environmental contamination Infection control Viral isolation

Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 18 01 2022
revised: 30 04 2022
accepted: 03 05 2022
pubmed: 16 5 2022
medline: 27 7 2022
entrez: 15 5 2022
Statut: ppublish

Résumé

Data on the transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) remain conflicting. Airborne transmission is still debated. However, hospital risk control requires better understanding of the different modes of transmission. This study aimed to evaluate the frequency of, and factors associated with, environmental air and surface contamination in the rooms of patients with coronavirus disease 2019 in the acute phase of the disease. Sixty-five consecutive patients were included in this study. For each patient, seven room surfaces, air 1 m and 3 m from the patient's head, the inner surface of the patient's mask, and the outer surface of healthcare workers' (HCW) masks were sampled. Environmental contamination was assessed by quantitative reverse transcription polymerase chain reaction (RT-qPCR) for SARS-CoV-2 RNA on surfaces, air and masks. A viral isolation test was performed on Vero cells for samples with an RT-qPCR cycle threshold (Ct) ≤37. SARS-CoV-2 RNA was detected by RT-qPCR in 34%, 12%, 50% and 10% of surface, air, patient mask and HCW mask samples, respectively. Infectious virus was isolated in culture from two samples among the 85 positive samples with Ct ≤37. On multi-variate analysis, only a positive result for SARS-CoV-2 RT-qPCR for patients' face masks was found to be significantly associated with surface contamination (odds ratio 5.79, 95% confidence interval 1.31-25.67; P=0.025). This study found that surface contamination by SARS-CoV-2 was more common than air and mask contamination. However, viable virus was rare. The inner surface of a patient's mask could be used as a marker to identify those at higher risk of contamination.

Identifiants

pubmed: 35569577
pii: S0195-6701(22)00133-5
doi: 10.1016/j.jhin.2022.05.003
pmc: PMC9098885
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116-122

Informations de copyright

Copyright © 2022 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Références

Lancet. 2021 May 1;397(10285):1603-1605
pubmed: 33865497
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Clin Infect Dis. 2021 Nov 2;73(9):e2952-e2959
pubmed: 33098412
Eur J Clin Microbiol Infect Dis. 2020 Nov;39(11):2005-2011
pubmed: 32638221
Viruses. 2022 May 17;14(5):
pubmed: 35632816
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
Curr Opin Virol. 2018 Feb;28:142-151
pubmed: 29452994
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794447
Nat Commun. 2021 Jan 11;12(1):267
pubmed: 33431879
F1000Res. 2021 Mar 24;10:233
pubmed: 34136133
Int J Infect Dis. 2020 Nov;100:476-482
pubmed: 32949774
Nat Med. 2020 Jun;26(6):861-868
pubmed: 32327757
Clin Infect Dis. 2021 Oct 5;73(7):e1870-e1877
pubmed: 32634826
Sci Rep. 2020 Jul 29;10(1):12732
pubmed: 32728118
J Infect. 2021 Mar;82(3):e35-e37
pubmed: 33248218
J Infect. 2021 Feb;82(2):282-327
pubmed: 32871179
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666
pubmed: 32442256
Sci Rep. 2020 Nov 11;10(1):19589
pubmed: 33177563
J Infect. 2021 Jun;82(6):253-259
pubmed: 33774019
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1059-1061
pubmed: 32342252
Clin Infect Dis. 2020 Dec 17;71(10):2667-2668
pubmed: 32504529
Int J Environ Res Public Health. 2020 Dec 26;18(1):
pubmed: 33375308
ERJ Open Res. 2020 Nov 10;6(4):
pubmed: 33257911
N Engl J Med. 2021 Apr 29;384(17):1677
pubmed: 33822492
Biomed Environ Sci. 2020 Dec 20;33(12):943-947
pubmed: 33472736
J Infect. 2020 Dec;81(6):847-856
pubmed: 33049331

Auteurs

S Nagle (S)

Unité de Prévention du Risque Infectieux, Service de Microbiologie clinique, Groupe Hospitalier Paris Seine Saint-Denis, Université Sorbonne Paris Nord, Bobigny, France; Réanimation Polyvalente, Groupe Hospitalier Paris Seine Saint-Denis, Université Sorbonne Paris Nord, Bobigny, France; INSERM UMR 1137 IAME, Université de Paris and Université Sorbonne Paris Nord, Bobigny, France.

Y Tandjaoui-Lambiotte (Y)

Réanimation Polyvalente, Groupe Hospitalier Paris Seine Saint-Denis, Université Sorbonne Paris Nord, Bobigny, France; INSERM UMR 1137 IAME, Université de Paris and Université Sorbonne Paris Nord, Bobigny, France; Pneumologie & Infectiologie, CH St Denis, Saint Denis, France; INSERM UMR 1272 Hypoxie & Poumon, Bobigny, Université Sorbonne Paris Nord, Bobigny, France.

M Boubaya (M)

Département de Recherche Clinique, Groupe Hospitalier Paris Seine-Saint-Denis, Assistance Publique-Hôpitaux de Paris, Paris, France.

G Athenaïs (G)

Unité de virologie, Service de Microbiologie Clinique, Groupe Hospitalier Paris Seine Saint-Denis, Université Sorbonne Paris Nord, Bobigny, France.

C Alloui (C)

Unité de virologie, Service de Microbiologie Clinique, Groupe Hospitalier Paris Seine Saint-Denis, Université Sorbonne Paris Nord, Bobigny, France.

C Bloch-Queyrat (C)

Département de Recherche Clinique, Groupe Hospitalier Paris Seine-Saint-Denis, Assistance Publique-Hôpitaux de Paris, Paris, France.

E Carbonnelle (E)

INSERM UMR 1137 IAME, Université de Paris and Université Sorbonne Paris Nord, Bobigny, France; Unité de virologie, Service de Microbiologie Clinique, Groupe Hospitalier Paris Seine Saint-Denis, Université Sorbonne Paris Nord, Bobigny, France.

S Brichler (S)

Unité de virologie, Service de Microbiologie Clinique, Groupe Hospitalier Paris Seine Saint-Denis, Université Sorbonne Paris Nord, Bobigny, France.

Y Cohen (Y)

Réanimation Polyvalente, Groupe Hospitalier Paris Seine Saint-Denis, Université Sorbonne Paris Nord, Bobigny, France.

J-R Zahar (JR)

Unité de Prévention du Risque Infectieux, Service de Microbiologie clinique, Groupe Hospitalier Paris Seine Saint-Denis, Université Sorbonne Paris Nord, Bobigny, France; INSERM UMR 1137 IAME, Université de Paris and Université Sorbonne Paris Nord, Bobigny, France; Unité de virologie, Service de Microbiologie Clinique, Groupe Hospitalier Paris Seine Saint-Denis, Université Sorbonne Paris Nord, Bobigny, France. Electronic address: jeanralph.zahar@aphp.fr.

H Delagrèverie (H)

INSERM UMR 1137 IAME, Université de Paris and Université Sorbonne Paris Nord, Bobigny, France; Unité de virologie, Service de Microbiologie Clinique, Groupe Hospitalier Paris Seine Saint-Denis, Université Sorbonne Paris Nord, Bobigny, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH